Soapbox
Body of endocannabinoid research makes compelling case for wider use
An exciting new area of research involves the endocannabinoid system (ECS) and the phyto-cannabinoid cannabidiol (CBD).
Soapbox
An exciting new area of research involves the endocannabinoid system (ECS) and the phyto-cannabinoid cannabidiol (CBD).
Non-scientific ‘soft’ claims on supplement packaging may be more powerful in communication than scientifically-backed health claims. But consumer opinions based on scientific claims are more robust in the face of negative or contradictory reports, say...
More than half of popular probiotics taken by people with coeliac contain traces of gluten, according to a new analysis.
Emerging methodologies and technologies such as the Smart Pill, non-invasive molecular methods using exfoliated epithelial cells, and uBiome, need further consideration and evaluation from key stakeholders to identify their validity as markers of...
A recently filed citizen's petition asking FDA to extend GMP requirements to ingredient manufacturers met with a cautious but generally positive reception among industry stakeholders. Having ingredient suppliers stand outside this aspect of the law was...
In a recently updated communication on marijuana, the Food and Drug Administration has flatly stated that products based on cannabidiol (CBD), a non-narcotic fraction of Cannabis sativa, cannot be marketed as dietary supplements. The reason? A...
Dispatches from Vitafoods, Geneva
Probiotic fruit drinks face different challenges to their dairy counterparts - but both face the same requirement to taste good.